ArticleBMC geriatrics2025
Association between magnesium level during hospitalization and venous thromboembolism (VTE) up to 30 days after hospitalization in acutely ill, hospitalized patients, 65 to 90 years old. a retrospective cohort analysis of 6,428 patients.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypomagnesemia, known to be associated with physiologic stress and states of inflammation, is also known to be common in acutely ill, hospitalized patients. The potential association between hypomagnesemia and increased risk for VTE (venous thromboembolism) is not well established.
methodsThis was a retrospective analysis of acutely ill, hospitalized elderly patients in a tertiary medical center.
resultsA cohort of 6,428 elderly hospitalized patients (57.8% males, median age 77 years (IQR 71-84)) included 3,007 (46.8%) with hypomagnesemia (Mg < 1.8 mg/dL). Amongst the hypomagnesemia group of patients, the median age was 76 (IQR 70-82). There was no significant difference in the rates of background thrombophilia between both study groups (0.4% vs. 0.3%; p = 0.47). Background malignancy more common in the hypomagnesemia group (6.7% vs. 4.3%; p < 0.001). Usage of proton pump inhibitors was more prevalent in the hypomagnesemia group (49.9% vs. 43%; p < 0.001). The occurrence of VTE by 30 days of admission was significantly higher amongst patients with hypomagnesemia (3% vs. 2.1%, OR = 1.45 CI95% 1.06-1.99; p = 0.02). In a multivariate analysis, controlling for age, gender, background malignancy, chronic kidney disease and thrombophilia, hypomagnesemia was still, independently associated with increased occurrence of 30-days VTE [OR = 1.42, CI95% 1.04-1.96; P = 0.029].
conclusionsAmongst hospitalized, acutely ill, elderly patients, hypomagnesemia is independently associated with an increased risk of VTE. Future prospective studies should reaffirm our findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.